SCM
Sarissa Capital Management’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-550,000
| Closed | -$699K | – | 11 |
|
|
2023
Q3 | $699K | Sell |
550,000
-2,082,900
| -79% | -$2.65M | 0.09% | 10 |
|
|
2023
Q2 | $8.66M | Sell |
2,632,900
-1,167,100
| -31% | -$3.84M | 0.86% | 7 |
|
|
2023
Q1 | $15.6M | Sell |
3,800,000
-197,010
| -5% | -$810K | 2% | 6 |
|
|
2022
Q4 | $23.4M | Hold |
3,997,010
| – | – | 2.79% | 6 |
|
|
2022
Q3 | $27M | Sell |
3,997,010
-302,287
| -7% | -$2.04M | 3.05% | 6 |
|
|
2022
Q2 | $19.9M | Hold |
4,299,297
| – | – | 2% | 7 |
|
|
2022
Q1 | $17.2M | Hold |
4,299,297
| – | – | 1.62% | 8 |
|
|
2021
Q4 | $26.7M | Hold |
4,299,297
| – | – | 2.31% | 8 |
|
|
2021
Q3 | $40.5M | Buy |
4,299,297
+293,697
| +7% | +$2.77M | 3.18% | 8 |
|
|
2021
Q2 | $54.4M | Hold |
4,005,600
| – | – | 4.33% | 8 |
|
|
2021
Q1 | $64.8M | Buy |
4,005,600
+1,078,600
| +37% | +$17.5M | 6.21% | 8 |
|
|
2020
Q4 | $77.9M | Buy |
2,927,000
+90,000
| +3% | +$2.39M | 7.95% | 7 |
|
|
2020
Q3 | $52.8M | Buy |
2,837,000
+267,000
| +10% | +$4.97M | 6.22% | 7 |
|
|
2020
Q2 | $60.1M | Sell |
2,570,000
-1,180,000
| -31% | -$27.6M | 6.69% | 7 |
|
|
2020
Q1 | $21.9M | Hold |
3,750,000
| – | – | 2.79% | 8 |
|
|
2019
Q4 | $21.5M | Hold |
3,750,000
| – | – | 1.78% | 10 |
|
|
2019
Q3 | $5.93M | Hold |
3,750,000
| – | – | 0.74% | 9 |
|
|
2019
Q2 | $15.2M | Hold |
3,750,000
| – | – | 1.89% | 9 |
|
|
2019
Q1 | $19.7M | Buy |
+3,750,000
| New | +$19.7M | 2.97% | 8 |
|